MetaCap

Pharming Group N.V. (PHAR) vs Verastem (VSTM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Pharming Group N.V. (PHAR) has outperformed Verastem (VSTM) over the past year, losing 29.0% versus a loss of 36.7%. Over five years, PHAR leads with a +39.0% price change compared with -80.3% for VSTM. Pharming Group N.V. is the larger company by market cap ($816.8 million vs $797.7 million), about 1.0 times the size, while Verastem is growing revenue faster (+209.1% vs +26.6%).

Pharming Group N.V. converts more of its revenue into profit, with a net margin of 0.8% versus -677.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PHAR-29.03%VSTM-36.70%
+35%-18%-70%
Nov 21, 20251 yearNov 20, 2026
PHAR+33.87%VSTM-82.18%
+149%+22%-105%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PHAR versus VSTM key metrics
MetricPHARVSTM
Share price$11.54$6.33
Market cap$816.78M$797.67M
1-day change-5.10%-7.73%
YTD return-34.69%-18.01%
1-year return-29.03%-36.70%
5-year return+39.04%-80.32%
P/E ratio (TTM)36.06—
Forward P/E64.11—
EPS (TTM)$0.32$-1.84
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$376.13M$30.91M
Revenue growth (YoY)+26.56%+209.14%
Net income (latest FY)$2.85M$-209.47M
Gross margin87.90%—
Operating margin6.87%-550.33%
Net margin0.76%-677.59%
52-week high$21.34$10.82
52-week low$9.11$3.43
Distance from 52-week high-45.92%-41.50%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+209.36%+172.04%
Average volume21.33K3.53M
Shares outstanding70.78M126.01M
Employees407102
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Pharming Group N.V. is more profitable, keeping 0.8 cents of every revenue dollar as net income versus -677.6 cents for Verastem.
  • Verastem grew revenue faster in its latest fiscal year (+209.14% vs +26.56%).

About Pharming Group N.V.

PHAR stock →

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Health Care · Biotechnology: Pharmaceutical Preparations · 407 employees

About Verastem

VSTM stock →

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors.

Health Care · Biotechnology: Pharmaceutical Preparations · 102 employees

PHAR vs VSTM FAQ

Which is bigger, Pharming Group N.V. or Verastem?

Pharming Group N.V. (PHAR) is larger, with a market capitalization of $816.78M compared with $797.67M for Verastem (VSTM).

Which stock has performed better over the past year, PHAR or VSTM?

PHAR returned -29.03% over the past 12 months, compared with -36.70% for VSTM (price return, excluding dividends). Past performance does not predict future results.

Are Pharming Group N.V. and Verastem in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons